 | Up a level |
Giannoudis, Athina 
ORCID: 0000-0002-7200-1497, Malki, Mohammed Imad, Rudraraju, Bharath, Mohhamed, Hisham, Menon, Suraj, Liloglou, Triantafillos ORCID: 0000-0003-0460-1404, Ali, Simak, Carroll, Jason S and Palmieri, Carlo ORCID: 0000-0001-9496-2718
(2020)
Activating transcription factor-2 (ATF2) is a key determinant of resistance to endocrine treatment in an in vitro model of breast cancer.
Breast Cancer Research, 22 (1).
126-.
Kirschner, Kristina, Samarajiwa, Shamith A, Cairns, Jonathan M, Menon, Suraj, Perez-Mancera, Pedro A, Tomimatsu, Kosuke, Bermejo-Rodriguez, Camino ORCID: 0000-0002-7554-1640, Ito, Yoko, Chandra, Tamir, Narita, Masako et al (show 6 more authors)
(2015)
Phenotype Specific Analyses Reveal Distinct Regulatory Mechanism for Chronically Activated p53.
PLOS GENETICS, 11 (3).
e1005053-.
Giannoudis, Athina ORCID: 0000-0002-7200-1497, Malki, Mohammed I, Mohammed, Hisham, Rudraraju, Bharath, Menon, Suraj, Ali, Simak, Carroll, Jason S and Palmieri, Carlo ORCID: 0000-0001-9496-2718
(2020)
The regulatory role of activating transcription factor-2 (ATF2) in modulating tamoxifen resistance in estrogen-receptor positive breast cancer.
In: San Antonio Breast Cancer Symposium, San Antonio, USA.